Munich, Germany

Dieter Hiendl

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Dieter Hiendl: Innovator in Nucleotide Sequencing

Introduction

Dieter Hiendl is a notable inventor based in Munich, Germany. He has made significant contributions to the field of nucleotide sequencing, particularly with his innovative patent related to 3' protected nucleotides. His work has implications for advancements in genetic research and biotechnology.

Latest Patents

Dieter Hiendl holds a patent for 3' protected nucleotides, which includes those having a detectable tag. This patent outlines systems and methods for sequencing nucleic acids using these nucleotides. Notably, it discusses techniques such as sequencing via nanopores and sequencing-by-synthesis, which are essential for modern genetic analysis.

Career Highlights

Hiendl is currently associated with Roche Sequencing Solutions, Inc., a leading company in the field of genetic sequencing. His role at Roche has allowed him to further develop his ideas and contribute to groundbreaking technologies in the industry.

Collaborations

Throughout his career, Dieter has collaborated with esteemed colleagues, including Frank Bergmann and Peter Crisalli. These partnerships have fostered an environment of innovation and have led to advancements in their shared field of expertise.

Conclusion

Dieter Hiendl's contributions to nucleotide sequencing through his patent and work at Roche Sequencing Solutions, Inc. highlight his role as a key innovator in biotechnology. His advancements are paving the way for future developments in genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…